Aurobindo Pharma gets USFDA nod for anti-infections drug

G. Naga Sridhar Hyderabad | Updated on March 12, 2018 Published on December 27, 2012

Aurobindo Pharma Ltd has received final approvals from the US Food & Drug Administration (USFDA) to manufacture and market Nafcillin injections.

Nafcillin for injection is a sterile semisynthetic penicillin (SSP) indicated in the treatment of infections caused by penicillinase-producing staphylococci which have demonstrated susceptibility to the drug.

It may be used to initiate therapy in suspected cases of resistant staphylococcal infections prior to the availability of susceptibility test results.

The products were ready for launch, the Hyderabad-based company said in a release.


Published on December 27, 2012
This article is closed for comments.
Please Email the Editor